2. Academic Validation
  3. Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis

Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis

  • J Pharm Biomed Anal. 2004 Apr 1;35(1):107-16. doi: 10.1016/j.jpba.2003.12.007.
M-H Spyridaki 1,  E Lyris,  I Georgoulakis,  D Kouretas,  M Konstantinidou,  C G Georgakopoulos
Affiliations

Affiliation

  • 1 Doping Control Laboratory of Athens, Olympic Athletic Center of Athens, Kifissias 37, 15123 Maroussi, Greece.
PMID: 15030885 DOI: 10.1016/j.jpba.2003.12.007
Abstract

Xylazine and its main metabolites were detected in equine urine after a single-dose intravenous administration of 0.98 and 1.01 mg/kg body weight xylazine, respectively, in two horses, in order to be used for equine doping control routine analysis. The urine levels of the parent drug and its metabolites were determined using gas chromatography-mass spectrometry (GC-MS). Xylazine is metabolised rapidly, down to a concentration level of about 1.0 microg/ml after 1-3h administration. Seven metabolites were identified in urine. 4-Hydroxy-xylazine, the major metabolite, could be traced for 25 h and it is regarded as the long-term metabolite of xylazine in horse. 2,6-Dimethylaniline was, for the first time, reported as metabolite in equine.

Figures
Products